Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Management of incidental adnexal masses
Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Incidental does not mean clinically inactive
Severe new pain, vomiting, collapse, peritonism, fever or pregnancy-related symptoms can reveal torsion, rupture, haemorrhage, abscess or ectopic pregnancy around a previously incidental mass.
Action: Move immediately to the relevant acute gynaecology or early-pregnancy pathway, assess ABCDE and pregnancy status, and do not wait for the planned outpatient characterisation scan.
Overview
Turn an unexpected adnexal finding into a safe age- and morphology-specific plan, avoiding both unnecessary intervention for low-risk simple cysts and delayed referral of complex or malignant disease.
An incidental adnexal mass is found during imaging performed for another reason and may not explain the presenting complaint. The first task is verification: review the original modality, radiologist description and images when available. CT can identify a pelvic lesion but often cannot describe fine ovarian morphology; a transvaginal ultrasound is usually needed unless MRI or CT has already demonstrated unequivocal benign or advanced malignant features. Confirm laterality and whether the structure is ovarian, paraovarian, tubal, uterine or extra-gynaecological.
Clinical context changes the same image. Establish menstrual and menopausal status, pregnancy possibility, symptoms, hormone use, endometriosis, previous pelvic surgery, fertility treatment and personal or family history of ovarian, breast, bowel or endometrial cancer. Examine for a mass, ascites, lymphadenopathy and tenderness when clinically relevant. A lesion discovered incidentally can still be symptomatic once directed questions reveal persistent abdominal distension, early satiety, pain or urinary change.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA
Amended postmenopausal threshold
A well postmenopausal patient has an incidental 2.8 cm unilateral, unilocular, completely simple ovarian cyst and no concerning symptoms. What does amended RCOG guidance advise?
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Before menopause, almost all ovarian masses are benign and many simple cysts are physiological. RCOG advises no routine follow-up for an asymptomatic simple cyst below 50 mm because resolution within three cycles is highly likely. A simple cyst measuring 50–70 mm receives yearly ultrasound. Above 70 mm, MRI or surgical intervention should be considered because ultrasound may not examine the entire wall adequately. Persistence, growth, complexity or symptoms override this simple size pathway.
After menopause, management uses ultrasound morphology and CA125 because baseline malignancy risk is higher. RCOG's December 2025 amendment states that an asymptomatic, unilateral, unilocular simple cyst of 3 cm or less requires no routine follow-up. If it is more than 3 cm but no more than 5 cm and CA125 is normal, repeat assessment in 4–6 months is reasonable. Discharge after one year is appropriate when it remains unchanged or shrinks and CA125 stays normal, taking surgical fitness and preference into account.
The conservative postmenopausal branch is narrow. Symptoms, non-simple architecture, size over 5 cm, multilocularity or bilateral lesions require further surgical evaluation even when RMI is low. Suspicious morphology or elevated risk leads to CT staging assessment and the gynaecological-oncology MDT. CA125 is the marker used for primary postmenopausal evaluation and RMI calculation, but it is nonspecific and normal values do not exclude ovarian cancer. Routine HE4, CEA, CA19-9, AFP, LDH or beta-hCG is not supported for primary postmenopausal cyst triage.
RMI I combines the ultrasound score, menopausal score and CA125. Ultrasound gains one point for each of multilocularity, solid areas, metastases, ascites and bilaterality; U is 0 for none, 1 for one and 3 for two or more. M is 1 before and 3 after menopause. RCOG uses 200 in its postmenopausal cyst pathway, whereas NICE CG122 refers suspected ovarian cancer at 250 or greater. Use the threshold specified by the governing local cancer pathway and document it.
A recognised benign non-simple pattern follows its disease-specific route. A likely dermoid, endometrioma or haemorrhagic cyst should not be forced into the simple-cyst table. Endometrioma merits specialist endometriosis referral; a dermoid needs growth, torsion and surgical discussion; a classic premenopausal haemorrhagic cyst may require short-interval resolution imaging according to size. An indeterminate lesion should receive expert ultrasound or MRI rather than an indefinite series of nonspecialist scans.
Surgery is chosen for symptoms, persistent growth, inability to characterise, acute complication or malignant risk. Laparoscopy is preferred for presumed benign masses in suitable patients, but extent differs by age: cystectomy can preserve premenopausal ovarian tissue, while RCOG advises bilateral salpingo-oophorectomy rather than cystectomy for postmenopausal laparoscopic management. Avoid intraperitoneal spill and use a retrieval bag where possible. Histology must be reviewed and any unexpected borderline or malignant result transferred promptly to oncology.
Key points
Verify the finding: obtain the original report and images, determine organ of origin, record maximum size and morphology, and establish whether the whole lesion was visible on CT, MRI or ultrasound.
Ask about pain, bloating, early satiety, urinary symptoms, bleeding, pregnancy possibility, menopause, endometriosis, fertility treatment, previous cancer and family history before calling a mass asymptomatic.
In premenopausal adults, a truly simple cyst smaller than 50 mm generally needs no follow-up; 50–70 mm simple cysts receive yearly ultrasound, while larger lesions merit MRI or surgical assessment.
In postmenopausal adults, RCOG's December 2025 update states that an asymptomatic unilateral unilocular simple cyst 3 cm or smaller needs no routine follow-up.
A postmenopausal simple unilateral unilocular cyst larger than 3 cm and up to 5 cm with normal CA125 can be reassessed in 4–6 months and discharged after one year if unchanged or smaller with normal CA125.
Postmenopausal symptoms, non-simple features, size above 5 cm, multilocularity or bilaterality move the lesion out of the low-risk conservative branch and into surgical or oncology assessment.
Use transvaginal ultrasound for definitive morphology when an incidental CT or MRI finding is not already diagnostic; add transabdominal views for large lesions.
Aetiology
01
Physiological ovarian change
Ovulation commonly produces follicles and corpus-luteum cysts that are discovered during imaging for unrelated abdominal or pelvic symptoms.
02
Persistent benign lesions
Dermoids, endometriomas, cystadenomas, paraovarian cysts and hydrosalpinges can remain clinically silent until cross-sectional imaging unexpectedly reveals them.
03
Occult neoplasia
Borderline and malignant tumours may initially be asymptomatic, making morphology, menopause and clinical risk essential despite incidental discovery.
Pathophysiology
1
Age-dependent baseline risk
Physiological cyst formation predominates during reproductive years, while epithelial malignant probability rises after menopause as ovulation ceases.
2
Progressive mass effect
Persistent lesions enlarge independently of menstrual cycles and eventually cause abdominal pressure, early satiety, urinary frequency or bowel symptoms.
3
Morphological evolution
Growth can reveal septa, nodules, papillary tissue or vascular solid components that materially change malignancy probability over time.
4
Mechanical accidents
Even a benign silent mass can twist its pedicle, bleed internally or rupture, suddenly converting surveillance into emergency care.
Clinical features and red flags
Low-risk premenopausal simple cyst
A fully seen asymptomatic simple cyst below 50 mm fits the no-routine-follow-up branch before menopause.
Low-risk postmenopausal simple cyst
An asymptomatic unilateral unilocular simple cyst 3 cm or smaller requires no routine follow-up under the amended RCOG pathway.
Conservative follow-up candidate
A postmenopausal cyst over 3 cm through 5 cm qualifies only when simple, unilateral, unilocular, asymptomatic and accompanied by normal CA125.
Complex risk pattern
Solid tissue, papillary projections, multilocularity, bilaterality, ascites or metastatic features require specialist assessment beyond a simple-cyst schedule.
Acute conversion
Sudden pain, vomiting, collapse or fever means the incidental finding may have torsed, ruptured, bled or become infected.
Persistent bloating, early satiety, pelvic or abdominal pain, urinary urgency or frequency and unexplained weight loss can make an incidental lesion clinically suspicious, especially after menopause.
Acute unilateral pain with vomiting can be torsion despite a benign earlier report or preserved Doppler flow and needs urgent surgical review.
Investigations
01Original-image and report reviewFirst step
Why
Verify organ of origin, dimensions, morphology, temporal comparison and whether the entire lesion was visualised.
Interpretation and limitations
A vague CT phrase such as adnexal cyst usually needs targeted ultrasound; clearly advanced malignant findings require direct oncology escalation.
02Transvaginal ultrasound
Why
Characterise wall, locules, internal echoes, solid tissue, papillae, vascularity, both ovaries and pelvic free fluid.
Interpretation and limitations
Only unequivocally simple morphology enters size-based conservative pathways; recognised benign, suspicious and indeterminate patterns follow separate routes.
03Serum CA125 after menopause
Why
Contribute to initial postmenopausal cyst assessment and RMI I calculation.
Interpretation and limitations
Normal CA125 permits conservative care only with the specified simple morphology and size; it never independently excludes ovarian malignancy.
04Age-specific tumour markers
Why
Evaluate suspected non-epithelial malignancy in younger patients with a complex ovarian mass.
Interpretation and limitations
For patients under 40, add AFP, beta-hCG and LDH while arranging specialist assessment; no marker replaces morphology or histology.
05
Differential diagnosis
01
Paraovarian cyst
A simple cyst separate from a normally visualised ovary arises from broad-ligament tissues and follows its own anatomical assessment.
02
Hydrosalpinx
A tubular folded fluid-filled structure with incomplete septa and separate ovary suggests chronic tubal distension rather than ovarian cyst.
03
Pedunculated fibroid
A solid vascular mass continuous with uterine myometrium can mimic an ovarian neoplasm when the connecting pedicle is not shown.
04
Non-gynaecological mass
Appendiceal, bowel, retroperitoneal or renal lesions can occupy the adnexal region and require organ-of-origin confirmation before treatment.
Management
01Finding verificationConvert an incidental phrase into morphologyFirst stepCT, MRI or non-specialist ultrasound reports an unexpected adnexal lesion.+
1Retrieve the report and images, compare prior studies and confirm size, laterality, menopausal status, symptoms and pregnancy possibility.
2DefinitiveArrange expert transvaginal ultrasound with transabdominal supplementation unless the existing study already provides adequate definitive characterisation.
3Route acute symptoms immediately and assign the non-acute result to a named clinician who will communicate the plan.
02Premenopausal simple cystUse physiological size thresholdsA fully visualised asymptomatic simple cyst is confirmed before menopause.+
1Discharge without routine imaging when smaller than 50 mm, explaining likely resolution and acute cyst-accident symptoms.
Complications
01
Delayed cancer referral
Premature reassurance from an incidental label or normal marker can postpone specialist staging and appropriate oncological surgery.
02
Unnecessary oophorectomy
Operating on low-risk physiological cysts exposes patients to anaesthesia, adhesions, ovarian tissue loss and avoidable surgical menopause.
03
Cyst accident
Torsion, rupture or haemorrhage can occur during observation, requiring explicit acute safety-netting rather than passive scan scheduling.
04
Surveillance burden
Open-ended imaging creates anxiety, false-positive change and resource use without a clear clinical endpoint or proven patient benefit.
Monitoring and follow-up
Document the exact criteria supporting conservative care so a later reviewer can see why the lesion qualified.
Track interval ultrasound and CA125 together in the postmenopausal 3–5 cm branch and reset the pathway if symptoms or morphology change.
Use the planned endpoint: resolution, one-year stable discharge, definitive reclassification or referral, rather than open-ended annual scanning.
Reassess family history and new ovarian-cancer symptoms at review because clinical risk can change even when size is stable.
Ensure the final histology from any operation reaches both the patient and responsible team, with oncology transfer for unexpected disease.
Special situations
Three centimetres changed in 2025
RCOG now advises no routine follow-up for asymptomatic postmenopausal unilateral unilocular simple cysts measuring 3 cm or less.
Incidental is a discovery route
The word describes how a lesion was found, not whether it is benign, asymptomatic or exempt from acute complications.
Simple pathways are narrow
One septum, solid area, papilla, symptom or bilateral lesion moves a mass outside the conservative postmenopausal algorithm.
CT does not replace cyst morphology
Cross-sectional imaging may discover the mass, but targeted ultrasound usually provides the wall and internal detail needed for triage.
Discharge needs an endpoint
A stable low-risk cyst should eventually leave surveillance; indefinite scanning adds anxiety and incidental change without proven benefit.
Common pitfalls
01
Applying premenopausal simple-cyst thresholds to a postmenopausal patient or vice versa.
02
Repeating CT for an incompletely described adnexal cyst instead of obtaining appropriate transvaginal morphology.
03
Using a normal CA125 to reassure a symptomatic or complex postmenopausal mass.
04
Following a dermoid, endometrioma or haemorrhagic lesion with the simple-cyst table despite different natural histories.
05
Writing annual ultrasound indefinitely without a named owner, stopping rule or escalation criteria.
06
Letting the incidental label delay acute torsion, rupture, bleeding, infection or ectopic-pregnancy assessment.
Assign every observation plan to a named clinician, specify the interval and endpoint, and provide urgent safety-netting rather than writing repeat scan without ownership.
A positive pregnancy test with pain, bleeding or free fluid requires pregnancy-location assessment rather than routine cyst surveillance.
A complex mass in a patient under 40 needs germ-cell marker assessment and specialist triage; a normal CA125 alone is not reassuring.
Pelvic MRI
Why
Resolve an ultrasound-indeterminate lesion, characterise blood or fat and map a mass too large for complete sonographic assessment.
Interpretation and limitations
MRI is a problem-solving examination rather than routine surveillance for a confidently simple low-risk cyst.
06CT abdomen and pelvis
Why
Assess extent when clinical findings, ultrasound and markers suggest ovarian malignancy or another abdominal primary.
Interpretation and limitations
CT supports oncology planning after risk is identified; it should not replace high-resolution ultrasound for initial cyst morphology.
2
Arrange yearly ultrasound for 50–70 mm lesions and ensure persistence or morphological change prompts gynaecology review.
3For a lesion larger than 70 mm, seek MRI or surgical assessment because complete ultrasound evaluation is unreliable.
03Postmenopausal simple cystApply the amended conservative branchA postmenopausal lesion is asymptomatic, unilateral, unilocular and completely simple.+
1For 3 cm or less, provide reassurance and no routine follow-up under the December 2025 RCOG amendment.
2For more than 3 cm through 5 cm, measure CA125 and, if normal, repeat CA125 and ultrasound in 4–6 months.
3Discharge after one year if unchanged or smaller with persistently normal CA125, incorporating wishes and operative fitness.
04Outside conservative criteriaEscalate complexity, symptoms or growthEscalationThe lesion is symptomatic, persistent complex, larger than pathway limits, bilateral, multilocular or associated with risk features.+
1Complete age-appropriate markers and morphology-based risk assessment, using RMI or IOTA according to menopause and service pathway.
2Refer malignant-pattern or threshold-positive disease to gynaecological oncology and indeterminate lesions for expert ultrasound or MRI.
3Plan surgery in the appropriate service with spill avoidance, consent for possible oophorectomy and guaranteed histology review.